A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Name: A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Published: 2025
License: Public Domain

Bristol-Myers Squibb · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

lung-cancer pancreatic-cancer

advanced solid malignancies, non-small cell lung cancer (nsclc), colorectal cancer (crc), pancreatic ductal adenocarcinoma (pdac), pancreatic cancer, lung cancer, kirsten rat sarcoma viral oncogene homolog (kras), interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Related documents